04:11 AM EDT, 08/06/2025 (MT Newswires) -- Adaptive Biotechnologies ( ADPT ) reported a Q2 loss Tuesday of $0.17 per diluted share, narrower than a loss of $0.31 a year earlier.

Three analysts polled by FactSet expected a loss of $0.25.

Revenue for the quarter ended June 30 was $58.9 million compared with $43.2 million a year earlier.

Analysts surveyed by FactSet expected $49.4 million.